Physician profile
Jeffrey Lankowsky
NPI 1558725333
$1,707.44
in general payments reported to CMS, 2019-2025
19 companies · $667 in 2025
The $667 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $41.67 · 2023: $572 · 2024: $426 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,399 · Education: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.80 |
| Education | $266.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $605.56 | 2023-2025 | |
| Actelion Pharmaceuticals US, INC. | $168.98 | 2023-2024 | Uptravi, Opsumit |
| Verona Pharma, INC. | $114.06 | 2025 | Ohtuvayre |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.42 | 2023-2025 | Spiriva Respimat, Stiolto Respimat, Jascayd |
| Sanofi-Aventis U.S. LLC | $97.99 | 2025 | |
| Mylan Specialty L.P. | $80.92 | 2023 | Yupelri |
| Amgen INC. | $71.40 | 2023-2024 | Tezspire, Repatha |
| Philips North America LLC | $63.55 | 2023-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Regeneron Healthcare Solutions, INC. | $61.76 | 2023 | Dupixent |
| Glaxosmithkline, LLC. | $59.71 | 2023-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Genentech USA, INC. | $50.86 | 2023-2025 | Xolair |
| Electromed, INC. | $48.14 | 2025 | Smartvest |
| United Therapeutics Corporation | $41.67 | 2022 | |
| Lilly USA, LLC | $40.11 | 2024 | Jardiance, Zepbound |
| Mallinckrodt Hospital Products INC. | $23.17 | 2025 | Acthar |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $23.06 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Abbvie INC. | $22.99 | 2023 | |
| Xeris Pharmaceuticals, INC. | $21.28 | 2023 | Gvoke Hypopen |
| Viatris Specialty LLC | $13.81 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Lankowsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.